Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment.

Mol Psychiatry · 2015 · PMC4759098 · PMID 26055427

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

showed a trendP =0.11not close (p > 0.1)

Baseline results showed a trend towards elevated SUVR CTX/CBL (+4.2% P =0.11) in the TG-GSM group compared with TG-VEH, mainly driven by the three individual animals mentioned above (labeled with arrows in Figure 3a ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.